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Abstract
A seroprevalence study was carried out in the region of Mar-
seille (south-eastern France) to address the public health impor-
tance of sandﬂy fever Sicilian virus (SFSV) and SFSV-like viruses,
as recently recognized vectors of those viruses are present in
this area. The low seroprevalence rate observed in this study
suggests that SFSV is not likely to be of major medical impor-
tance in the Marseille area.
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Sandﬂy fever viruses (genus Phlebovirus, family Bunyaviridae)
cause signiﬁcant health problems in many regions of the
world, including the Mediterranean basin [1,2]. In this area,
most recent human cases have been caused by Toscana
virus, a genotype of the species. Sandﬂy fever Naples virus.
Sandﬂy fever Sicilian virus (SFSV) is a distinct arthropod-
borne virus, ﬁrst identiﬁed in Italy (Palerma, Sicilia) during
World War II, where it affected troops of the Allied armed
forces after the Sicily landings in 1943. SFSV is transmitted
by sandﬂies during their blood feeding, speciﬁcally by Phlebo-
tomus papatasi. The virus is spread during the warm season,
i.e. the active period of the vector. SFSV infection causes rel-
atively mild symptoms (fever, headache, and muscle and joint
pain) and is not neurotropic; patients usually recover fully
within a week [3].
Case reports of human cases and seroprevalence studies
have suggested that SFSV, or an SFSV-like virus, circulates in
Italy, Egypt, Pakistan, Iran, Cyprus, Jordan, Israel, Sudan, Tuni-
sia, Pakistan, Egypt, Bangladesh, and Iran [2]. However, most
of these studies are old, and the current situation is poorly
understood. There is no documented case of SFSV infection
in France. Recently, molecular evidence was reported for the
presence of two distinct phleboviruses closely related to
SFSV in Algeria [4] and Tunisia [5]. SFSV-like virus RNA was
detected in Phlebotomus ariasi in Algeria [4,6], and in Phleboto-
mus perniciosus and Phlebotomus longicuspis in Tunisia [5].
Interestingly, these three species of sandﬂy belong to the sub-
genus Larroussius, and may be alternative vectors of SFSV and/
or SFSV-like viruses. As P. perniciosus and P. ariasi circulate at
high levels in southern France, in contrast to P. papatasi, we
decided to address the public health importance of SFSV and
SFSV-like viruses by conducting a seroprevalence study with
sera of patients living in the Marseille region.
A total of 198 sera were randomly taken from the serum
collection of the parasitology laboratory in the AP-HM Ti-
mone Hospital of Marseille. Following national regulations
regarding biomedical research (Huriet-Se´rusclat law), the
patient’s signature at the hospital entrance ofﬁce means that
all specimens collected during hospitalization for diagnostic
purpose are accessible for research (excluding human genetic
research), without speciﬁc consent of the patient. Informa-
tion on patient sex, date of birth, home location and date of
hospital admission was compiled. All sera were collected
from patients hospitalized between May 2009 and May 2010.
All patients were living in Marseille and its suburbs. Samples
were tested for SFSV IgG by indirect immunoﬂuorescence
assay, as previously described [6].
The tested population sample was composed of 101 males
and 97 females, and the mean age was 47.6 years. The
presence of IgG speciﬁc for SFSV or SFSV-like virus was
observed in 2/198 sera (1%). Positive sera were from a 38-
year-old male and a 43-year-old female (Fig. 1). This result is
in agreement with previous data obtained in France more
than 20 years ago. In 1969, a serological survey carried out
in the south-west of France (Central Pyrenees) showed that
only 2% of human sera of the region contained SFSV-speciﬁc
IgG [7]. In 1987, a serosurvey performed in large wild mam-
mals reported that 0.3% of sera reacted against SFSV in hae-
magglutination inhibition assays [8]. Although the presence of
P. papatasi has been conﬁrmed in the south of France, this
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species is rare, in agreement with the low seroprevalence
rates. Moreover, one can argue that these two patients
acquired SFSV infection outside of France. One of the two
positive patients could be contacted, and he reported several
vacation trips to North Africa, during which infection with
SFSV could have occurred, although he did not recall fever
during or after the trips. As the seroprevalence rates
observed with Toscana virus are much higher [9], it is
important to underline that there is no cross-reactivity
between Toscana virus and SFSV in immunoﬂuorescence
assays. Nevertheless, sandﬂies are common in the south of
France, where they are known to be vectors of Toscana
virus [9,10], one of the main agents of summer fever and
aseptic meningitis in Mediterranean countries. SFSV-like
viruses have been recently reported in sandﬂies other than
P. papatasi in Algeria and Tunisia [4–6]. In Algeria, 5% of the
tested sera contained antibodies reacting against SFSV [6].
Together, these ﬁndings raise the possibility that SFSV might
be circulating signiﬁcantly in south-eastern France through
sandﬂy vectors other than P. papatasi. The present study
does not support this hypothesis.
In conclusion, the low seroprevalence rates observed here
for SFSV and SFSV-like viruses, together with the lack of
documented cases of infection in the literature, suggest that
SFSV is not likely to be of major medical importance in the
Marseille area. This remains to be conﬁrmed in other regions
of France where sandﬂies are present.
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FIG. 1. Age distribution of the 198 patients tested for SFSV IgG.
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